DA
PFE icon

Dover Advisors’s Pfizer PFE Stock Holding History

Dover Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$284K Buy
11,398
+1,059
+10% +$27.7K 0.12% 132
2026
Q1 		$290K Sell
10,339
-1,059
-9% -$28.2K 0.12% 137
2025
Q4 		$284K Sell
11,398
-2,922
-20% -$73.7K 0.11% 140
2025
Q3 		$365K Sell
14,320
-370
-3% -$9.13K 0.15% 120
2025
Q2 		$356K Sell
14,690
-7,943
-35% -$185K 0.16% 115
2025
Q1 		$574K Buy
22,633
+8,824
+64% +$231K 0.25% 89
2024
Q4 		$366K Sell
13,809
-968
-7% -$26.3K 0.21% 96
2024
Q3 		$428K Sell
14,777
-1,165
-7% -$34K 0.24% 89
2024
Q2 		$446K Sell
15,942
-6,617
-29% -$182K 0.28% 87
2024
Q1 		$626K Buy
22,559
+7,454
+49% +$207K 0.43% 70
2023
Q4 		$435K Sell
15,105
-5,876
-28% -$178K 0.57% 58
2023
Q3 		$696K Sell
20,981
-43
-0.2% -$1.52K 0.7% 51
2023
Q2 		$771K Sell
21,024
-1,688
-7% -$65.7K 0.68% 50
2023
Q1 		$927K Buy
22,712
+2,540
+13% +$110K 0.89% 36
2022
Q4 		$1.03M Buy
+20,172
New +$967K 1.11% 29

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Dover Advisors's PFE Position: Q2 2026 in Review

Dover Advisors increased its Pfizer (PFE) stake by 10% in Q2 2026, buying an estimated $27.7K and bringing the position to 11,398 shares worth $284K. The position accounts for 0.12% of the portfolio, ranked #132.

Dover Advisors first reported a position in PFE in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.03M in Q4 2022. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Dover Advisors held 11,398 shares of Pfizer worth $284K as of Q2 2026.
  • Dover Advisors bought 1,059 Pfizer shares in Q2 2026, an estimated $27.7K.
  • Pfizer made up 0.12% of Dover Advisors's portfolio in Q2 2026, its #132 holding.
  • Dover Advisors first reported a position in Pfizer in Q4 2022 and has held it in 15 quarters since.
  • Dover Advisors's Pfizer position peaked at $1.03M in Q4 2022.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Dover Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.